3D Printing Technologies in Pharmaceutical Formulation

Dear Colleagues,

We are pleased to invite you to the Special Issue “3D Printing Technologies in Pharmaceutical Formulation”. 3D printing of medication is an emerging area that is getting a lot of attention due to its versatility and ability to personalize medication and help address the gap between the need and the market availability. The importance has risen recently due to the improvements in the technology of 3D printing and the increased demand for personalized medication. Additionally, the use of bioprinting has been on the rise, providing a way to sculpture tissue and organs, which has massively improved the lives of many patients.

This Special Issue aims to capture the new development in pharmaceutical 3D printing, whether for printing out medication or even for the use of bioprinters and the new improvements in that field. Moreover, there will be some focus on 4D printing, which is a new development in 3D printing.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:

1. FDM 3D printing.
2. Extrusion printing.
3. SLA printing.
4. SLS printing.
5. Inkjet bioprinting.
6. Extrusion bioprinting.
7. Pressure based bioprinting.
8. Laser-assisted bioprinting.
9. 4D printing.

I look forward to receiving your contributions.

Dr. Abdullah Isreb
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.